AIFF — Firefly Neuroscience, Inc.
$0.9196-9.84%
Last close: · regular session
After-hours $0.9300 +1.13% ·
Last 60 sessions
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for AIFF in the TickerWise workspace.
Based in Toronto, Canada, Firefly Neuroscience, Inc. is a medical technology and artificial intelligence firm specializing in developing neuroscientific solutions. The company's primary goal is to enhance patient outcomes for individuals affected by mental illnesses and neurological disorders. Its flagship product, Brain Network Analytics, is a sophisticated software platform engineered to aid in the diagnosis and treatment of a diverse range of cognitive and psychiatric conditions. These conditions encompass, but are not limited to, depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. Firefly Neuroscience, Inc. caters to both pharmaceutical companies and medical practitioners.
Company profile
- Sector: Technology
- Industry: Software - Application
- Country: US
- Exchange: NASDAQ Global Market
- Employees: 13
- Website: https://fireflyneuro.com
Latest SEC filings for AIFF
Latest AIFF news
- Why Did Firefly Neuroscience Stock Soar Today?
- AI Stock Firefly Neuroscience (NASDAQ: AIFF) Soars on First FDA-Cleared, Non-Drug Treatment for Pediatric ADHD
- Firefly Neuroscience Surges as Investors Appear to Cheer New Commercial Partnership Momentum
- Firefly Neuroscience and Neurosigma Partner To Expand Non-Drug Pediatric ADHD Care Read article
- Biotech Pre-Market Movers: AIFF, JAGX Surge; CDT, GCTK Slide
- AIFF Stock Jumps As Traders Chase Volatile Spike
- AIFF Stock Pops On Volatile Run As Traders Eye Cash Cushion
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.